Cargando…

Temozolomide-Induced Shrinkage of Invasive Pituitary Adenoma in Patient with Nelson's Syndrome: A Case Report and Review of the Literature

Introduction. Invasive tumours in Nelson's syndrome need aggressive therapy. Recent reports have documented the efficacy of temozolomide (TMZ) in the treatment of adenomas resistant to conventional management. Objective. The review of the literature concerning TMZ treatment of atypical corticot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kurowska, Maria, Nowakowski, Andrzej, Zieliński, Grzegorz, Malicka, Joanna, Tarach, Jerzy S., Maksymowicz, Maria, Denew, Piotr
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2015
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499620/ https://www.ncbi.nlm.nih.gov/pubmed/26221547 http://dx.doi.org/10.1155/2015/623092

Ejemplares similares

Double pituitary adenomas in a large surgical series
por: Zieliński, Grzegorz, et al.
Publicado: (2019)

Double, Synchronous Pituitary Adenomas Causing Acromegaly and Cushing’s Disease. A Case Report and Review of Literature
por: Zieliński, Grzegorz, et al.
Publicado: (2013)

Thyroid diseases in patients with acromegaly
por: Dąbrowska, Anna Maria, et al.
Publicado: (2013)

Temozolomide in aggressive pituitary adenomas and carcinomas
por: Ortiz, Leon D., et al.
Publicado: (2012)

Difference in miRNA Expression in Functioning and Silent Corticotroph Pituitary Adenomas Indicates the Role of miRNA in the Regulation of Corticosteroid Receptors
por: Mossakowska, Beata J., et al.
Publicado: (2022)

Increased expression of the microRNA 106b~25 cluster and its host gene MCM7 in corticotroph pituitary adenomas is associated with tumor invasion and Crooke’s cell morphology
por: Garbicz, Filip, et al.
Publicado: (2017)

SAT-265 An Asynchronous Double Growth Hormone Secreting Pituitary Adenoma as a Cause of Rapid Tumor Regrowth After Initially Successful Surgery
por: Trofimiuk-Muldner, Malgorzata, et al.
Publicado: (2020)

Aggressive Pituitary Macroadenoma Treated With Capecitabine and Temozolomide Chemotherapy Combination in a Patient With Nelson’s Syndrome: A Case Report
por: Mirallas, Oriol, et al.
Publicado: (2021)

Temozolomide-Induced Shrinkage of a Pituitary Carcinoma Causing Cushing's Disease — Report of a Case and Literature Review
por: Curtò, Lorenzo, et al.
Publicado: (2010)

The role of somatostatin analogues in treatment of TSH secreting pituitary adenomas
por: Zgliczyński, Wojciech, et al.
Publicado: (2013)

Clinicopathological predictive factors in the early remission of corticotroph pituitary macroadenomas in a tertiary referral centre
por: Witek, Przemysław, et al.
Publicado: (2016)

Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways
por: Grzywa, Tomasz M., et al.
Publicado: (2019)

SUN-272 Significant Response to Temozolomide in Two Aggressively Growing Pituitary Adenomas
por: Kreitschmann-Andermahr, Ilonka, et al.
Publicado: (2020)

Early Initiation of Temozolomide Therapy May Improve Response in Aggressive Pituitary Adenomas
por: Das, Liza, et al.
Publicado: (2021)

Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing’s Disease
por: Rak, Beata, et al.
Publicado: (2021)

Pasireotide-Induced Shrinkage in GH and ACTH Secreting Pituitary Adenoma: A Systematic Review and Meta-Analysis
por: Mondin, Alessandro, et al.
Publicado: (2022)

Treatment of Aggressive Prolactin-Secreting Pituitary Adenomas with Adjuvant Temozolomide Chemotherapy: A Review
por: Moisi, Marc, et al.
Publicado: (2016)

Differential microRNA Expression in USP8-Mutated and Wild-Type Corticotroph Pituitary Tumors Reflect the Difference in Protein Ubiquitination Processes
por: Bujko, Mateusz, et al.
Publicado: (2021)

The Expression of Cell Cycle-Related Genes in USP8-Mutated Corticotroph Neuroendocrine Pituitary Tumors and Their Possible Role in Cell Cycle-Targeting Treatment
por: Mossakowska, Beata Joanna, et al.
Publicado: (2022)

Nelson
por: Southey, Robert
Publicado: (1945)

Nelson
por: Southey, Robert
Publicado: (1984)

Nelson
por: Southey, Robert
Publicado: (1945)

Analysis of whole genome-wide microRNA transcriptome profiling in invasive pituitary adenomas and non-invasive pituitary adenomas
por: Zhang, Chao, et al.
Publicado: (2019)

Enlargement of an incidental internal carotid artery aneurysm embedded in pituitary adenoma associated with medical shrinkage of the tumor: Case report
por: Khachatryan, Tigran, et al.
Publicado: (2018)

The Search of miRNA Related to Invasive Growth of Nonfunctioning Gonadotropic Pituitary Tumors
por: Boresowicz, Joanna, et al.
Publicado: (2020)

A Rapid Biochemical and Radiological Response to the Concomitant Therapy with Temozolomide and Radiotherapy in an Aggressive ACTH Pituitary Adenoma
por: Misir Krpan, Ana, et al.
Publicado: (2017)

Nonfunctioning giant pituitary adenomas: Invasiveness and recurrence
por: Landeiro, José Alberto, et al.
Publicado: (2015)

Role of matrix Metalloproteinases in pituitary adenoma invasion
por: Yang, Chengxian, et al.
Publicado: (2018)

Clinical, hormonal and pathomorphological markers of somatotroph pituitary neuroendocrine tumors predicting the treatment outcome in acromegaly
por: Tomasik, Agnieszka, et al.
Publicado: (2022)

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly
por: Rymuza, Julia, et al.
Publicado: (2022)

The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing’s disease and silent corticotroph tumors
por: Kober, Paulina, et al.
Publicado: (2023)

Nelson Mandela /
por: Mandela, Nelson, 1918-
Publicado: (2004)

Nelson Mandela
por: Benson, Mary
Publicado: (1980)

Nelson Hospital
Publicado: (1912)

Nelson-Salassa Syndrome Progressing to Pituitary Carcinoma: A Case Report and Review of the Literature
por: Carlstrom, Lucas P, et al.
Publicado: (2019)

Nelson : Compendio de pediatría
Publicado: (1991)

Long-term remission in an aggressive Crooke cell adenoma of the pituitary, 18 months after discontinuation of treatment with temozolomide
por: Asimakopoulou, Athina, et al.
Publicado: (2014)

Pituitary Adenoma Surgery Survey: Neurosurgical Centers and Pituitary Adenomas
por: Netuka, David, et al.
Publicado: (2022)

Survivin overexpression is potentially associated with pituitary adenoma invasiveness
por: Kong, Xiangyi, et al.
Publicado: (2017)

SIRT1 Contributes as an Invasiveness Marker in Pituitary Adenoma
por: Vaiciulis, Domantas, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6qpig4u3unf9u5ufi9vnd0bc47